Soberlink - MAP Outcomes Study Protocol

Stopped early

Conditions studied: Alcohol Addiction

In brief

The purpose of this study is to show the effectiveness of Soberlink's remote alcohol monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample size of at-risk alcohol use disorder (AUD) population. Ultimately, this data is leveraged to improve clinical outcomes and manage financial risk through facilitating early interventions and other means of mitigating recidivism and costly treatment episodes from AUD population.

Key facts

Study ID

NCT03190356

Run by

Soberlink Healthcare LLC

People needed

6

Starts

2017-08-22

Expected to finish

2018-04-27

Last updated by the study team

2018-05-15

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subject between ages of 21-65 years old
• Subject is active in MAP's program with recovery support services
• Subject has received acute professional treatment in the last 120 days
• Primary or secondary diagnosis is Alcohol Use Disorder
• Subject willing to use Soberlink Device to provide BAC
• Subject is willing to discuss Soberlink test results with case manager
• Subject is willing to sign a Soberlink Client Agreement
• Subject is English speaking and reading

You may not qualify if…

• Alcohol Use Disorder is not a primary or secondary diagnosis
• Subject is currently taking anti-alcohol medications
• Subject will not be in the United States through duration of study
• Subject is unwilling to properly use the device
• Subject is non-English speaking and reading
• Subject is a child, adolescent, cognitively impaired, diagnosed with a mental disorder, such as schizophrenia

Where it is running

• MAP Health Management LLC — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.